Request for Information (RFI): Inviting Comments on the Future of the National Library of Medicine Biomedical and Data Science Extramural Research Programs
Notice NOT-LM-25-002 from the NIH Guide for Grants and Contracts
Notice of Correction to Application Due Dates for RFA-OD-24-011 "NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)"
Notice NOT-OD-25-089 from the NIH Guide for Grants and Contracts
Notice of Change to Advisory Council Review for PAR-25-131
Notice NOT-LM-25-001 from the NIH Guide for Grants and Contracts
Notice of Change: NINDS Participation in PAR-22-213 "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)"
Notice NOT-NS-25-021 from the NIH Guide for Grants and Contracts
Notice of Change to PAR-23-021, "Avenir Award Program for Genetic or Epigenetic of Substance Use Disorders (DP1 Clinical Trial Optional)"
Notice NOT-DA-24-062 from the NIH Guide for Grants and Contracts
Notice of Correction to RFA-HL-26-014 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
Notice NOT-HL-25-006 from the NIH Guide for Grants and Contracts
Notice of Change to PAR-25-139 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Notice NOT-CA-25-045 from the NIH Guide for Grants and Contracts
Notice of Change to PAR-23-065 NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Notice NOT-AI-25-025 from the NIH Guide for Grants and Contracts
RESCINDED - Notice of NIBIB Participation in PA-23-272: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
Notice NOT-EB-25-004 from the NIH Guide for Grants and Contracts
Notice of NIDCR Participation in PA-25-168, Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Notice NOT-DE-25-050 from the NIH Guide for Grants and Contracts
Notice to Applicants That the Simplified Review Framework Will be Applied to All Relevant Applications for August/October 2025 Councils
Notice NOT-OD-25-116 from the NIH Guide for Grants and Contracts
Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Notice NOT-NS-25-024 from the NIH Guide for Grants and Contracts
Notice of Need to Rescind NOT-AT-20-017 "NCCIH Policy Change to Budget Limit and Grant Durations for SBIR/STTR Phase I and Phase II Applications" to update NCCIH Policy Change to Budget Limit and Grant Durations for SBIR/STTR Phase I and Phase
Notice NOT-AT-25-004 from the NIH Guide for Grants and Contracts
Updated NIH Processes for No-Cost Extensions
Notice NOT-OD-25-110 from the NIH Guide for Grants and Contracts
Implementation Update: Improving the Safety and Security of Biological Research
Notice NOT-OD-25-112 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish the re-issuance of the Notice of Funding Opportunity (NOFO) Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
Notice NOT-TR-25-008 from the NIH Guide for Grants and Contracts
Notice to Extend the Expiration Date of PAR-25-045, NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
Notice NOT-DE-25-047 from the NIH Guide for Grants and Contracts
Updated NIH Policy on Foreign Subawards
Notice NOT-OD-25-104 from the NIH Guide for Grants and Contracts
Revision: Notice of Updated Effective Date for the 2024 NIH Public Access Policy
Notice NOT-OD-25-101 from the NIH Guide for Grants and Contracts
Notice of NHLBI Participation in PAR-25-143 "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)"
Notice NOT-HL-25-010 from the NIH Guide for Grants and Contracts
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.